Showing results (131-140 of 773) with videos related to

Sort By:
Pageof 78
Journal of the American College of Cardiology|February 12, 2011
The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levelsNiteesh K Choudhry, Amanda R Patrick, Robert J Glynn, et al.
BMJ Quality & Safety|April 27, 2013
Speaking the same language? International variations in the safety information accompanying top-selling prescription drugsAaron S Kesselheim, Jessica M Franklin, Jerry Avorn, et al.
JAMA|August 25, 2018
Medicare Spending on Brand-name Combination Medications vs Their Generic ConstituentsChana A Sacks, ChangWon C Lee, Aaron S Kesselheim, et al.
Plos One|March 28, 2014
Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysisKrista F Huybrechts, Reesha Shah Sanghani, Jerry Avorn, et al.
JAMA|September 24, 2014
Electronic medication packaging devices and medication adherence: a systematic reviewKyle D Checchi, Krista F Huybrechts, Jerry Avorn, et al.
JAMA Internal Medicine|May 22, 2023
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance InhalersWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim, et al.
BMJ Open|February 15, 2018
Adaptive design clinical trials: a review of the literature and ClinicalTrials.govLaura E Bothwell, Jerry Avorn, Nazleen F Khan, et al.
Circulation|December 21, 2006
Statins and the risk of lung, breast, and colorectal cancer in the elderlySoko Setoguchi, Robert J Glynn, Jerry Avorn, et al.
Archives of Internal Medicine|April 25, 2007
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patientsMichael A Fischer, Charles A Morris, Wolfgang C Winkelmayer, et al.
Pharmacoeconomics|October 27, 2007
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysisAmanda R Patrick, Wolfgang C Winkelmayer, Jerry Avorn, et al.
Pageof 78